NomoCan Pharmaceuticals offers first-in-kind targeted therapies for some of the most aggressive cancers with unmet medical need. Our platform technology not only makes available a selective and specific diagnostic and prognostic test for early detection, but more remarkably, it introduces a highly effective therapeutics for the treatment of various cancers in order to “Bring Hope” to patients affected by this devastating disease.
Company Details
- Employees
- 5
- Address
- 310 E 67th St, New York,10065,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- nomocan.com
- Keywords
- Encapsulate.
- HQ
- New York
Nomocan Pharmaceuticals Questions
Nomocan Pharmaceuticals's website is nomocan.com
Nomocan Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/nomocan-pharmaceuticals
Nomocan Pharmaceuticals has
5 employees.
View email and phone details for 5
employees at Nomocan Pharmaceuticals.
Nomocan Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Nomocan Pharmaceuticals's top competitors are
Celine Biotechnologies,
Chiara Biosciences,
Weill Cornell Medicine Enterprise Innovation,
Syntax Bio,
Saccharo Inc.,
Cl3 Med Solutions,
Aim-Hi Accelerator Fund,
Singular Immune,
Encapsulate,
Gals Bio Ltd.
Nomocan Pharmaceuticals's categories are Pharmaceutical Manufacturing
